Evidence map›Paper›PMID 27121568›Full record

ArticleScientific reports2016

A PARP1-ERK2 synergism is required for the induction of LTP.

L Visochek, G Grigoryan, A Kalal, H Milshtein-Parush, N Gazit, I Slutsky, A Yeheskel, A Shainberg, A Castiel, R Seger and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. 1,25-Dihydroxyvitamin DInternational journal of molecular sciences · 2024
    Article
  8. Role of NADCellular and molecular neurobiology · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Antidepressant-Like Actions of Inhibitors of Poly(ADP-Ribose) Polymerase in Rodent Models.The international journal of neuropsychopharmacology · 2017
    Article
  17. Article
  18. Signal-induced PARP1-Erk synergism mediates IEG expression.Signal transduction and targeted therapy
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

L VisochekNeufeld Cardiac Research institute, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.
G GrigoryanDepartment of Neurobiology, the Weizmann Institute of Science, Rehovot 76100, Israel.
A KalalNeufeld Cardiac Research institute, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.
H Milshtein-ParushDepartment of Physiology and Pharmacology, Tel-Aviv University, Tel-Aviv 69978, Israel.
N GazitDepartment of Physiology and Pharmacology, Tel-Aviv University, Tel-Aviv 69978, Israel.
I SlutskyDepartment of Physiology and Pharmacology, Tel-Aviv University, Tel-Aviv 69978, Israel.
A YeheskelBioinformatics Unit, George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 69978, Israel.
A ShainbergMina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, 52900 Ramat Gan, Israel.
A CastielCancer Research Center, Sheba Medical Center, 53621 Ramat Gan, Israel.
R SegerDepartment of Biological Regulation, the Weizmann Institute of Science, Rehovot 76100, Israel.
M F LangelierDepartment of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
F DantzerBiotechnology and Cell Signaling, UMR7242, Ecole Superieure de Biotechnologie Strasbourg, F-67400, Illkrich-Graffenstaden, France.
J M PascalDepartment of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA.
M SegalDepartment of Neurobiology, the Weizmann Institute of Science, Rehovot 76100, Israel.
M Cohen-ArmonNeufeld Cardiac Research institute, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.
Tel Aviv University · ILWeizmann Institute of Science · ILBar-Ilan University · ILÉcole Supérieure de Biotechnologie de Strasbourg · FRSheba Medical Center · ILSidney Kimmel Cancer Center · USThomas Jefferson University · US

Funding

Possible treatment of cocaine craving and relapse by memory erasureR21DA027776 · NIDA · BAR-ILAN UNIVERSITY · PI YADID, GAL MOSHE · 2009 to 2010
$197k
NIDA NIH HHS R21 DA027776
6 · The paper itself

Abstract

Unexpectedly, a post-translational modification of DNA-binding proteins, initiating the cell response to single-strand DNA damage, was also required for long-term memory acquisition in a variety of learning paradigms. Our findings disclose a molecular mechanism based on PARP1-Erk synergism, which may underlie this phenomenon. A stimulation induced PARP1 binding to phosphorylated Erk2 in the chromatin of cerebral neurons caused Erk-induced PARP1 activation, rendering transcription factors and promoters of immediate early genes (IEG) accessible to PARP1-bound phosphorylated Erk2. Thus, Erk-induced PARP1 activation mediated IEG expression implicated in long-term memory. PARP1 inhibition, silencing, or genetic deletion abrogated stimulation-induced Erk-recruitment to IEG promoters, gene expression and LTP generation in hippocampal CA3-CA1-connections. Moreover, a predominant binding of PARP1 to single-strand DNA breaks, occluding its Erk binding sites, suppressed IEG expression and prevented the generation of LTP. These findings outline a PARP1-dependent mechanism required for LTP generation, which may be implicated in long-term memory acquisition and in its deterioration in senescence.

Indexed as

Gene Expression RegulationLong-Term PotentiationAnimalsCA1 Region, HippocampalCA3 Region, HippocampalMiceMice, KnockoutMitogen-Activated Protein Kinase 1Poly (ADP-Ribose) Polymerase-1Protein BindingMapk1 protein, mouseMitogen-Activated Protein Kinase 1Parp1 protein, mousePoly (ADP-Ribose) Polymerase-1

Identifiers

PMID27121568
PMCPMC4848477
OpenAlexW2344276162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.